Literature DB >> 30877750

Hallucinations and Delusions Signal Alzheimer's Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms.

Joshua T Fuller1,2, Tabina K Choudhury3, Deborah A Lowe4, Steve Balsis5.   

Abstract

OBJECTIVES: Neuropsychiatric symptoms (NPS) are common among individuals with dementia of the Alzheimer's type (DAT). We sought to characterize which NPS more purely relate to cognitive dysfunction in DAT, relative to other NPS.
METHOD: Demographic, neurocognitive, neuroimaging, and NPS data were mined from the Alzheimer's Disease Neuroimaging Initiative database (n = 906). Using factor analysis, we analyzed the degree to which individual NPS were associated with DAT-associated cognitive dysfunction. We also employed item response theory to graphically depict the ability of individual NPS to index DAT-associated cognitive dysfunction across a continuum ranging from cognitively normal to mild DAT.
RESULTS: Psychotic symptoms (hallucinations and delusions) were more strongly related to the continuum of DAT-associated cognitive dysfunction than other NPS, with the strength of the relationship peaking at high levels of disease severity. Psychotic symptoms also negatively correlated with brain volume and did not relate to the presence of vision problems. Aberrant motor behavior and apathy had relatively smaller associations with DAT-associated cognitive dysfunction, while other NPS showed minimal associations. DISCUSSION: Psychotic symptoms most strongly indexed DAT-associated cognitive dysfunction, whereas other NPS, such as depression and anxiety, were not as precisely related to the DAT-associated cognitive dysfunction.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Mild cognitive impairment; Quantitative methods

Year:  2020        PMID: 30877750      PMCID: PMC7751129          DOI: 10.1093/geronb/gbz032

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  42 in total

Review 1.  Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Authors:  Clifford R Jack; Matt A Bernstein; Bret J Borowski; Jeffrey L Gunter; Nick C Fox; Paul M Thompson; Norbert Schuff; Gunnar Krueger; Ronald J Killiany; Charles S Decarli; Anders M Dale; Owen W Carmichael; Duygu Tosun; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  An adaptationist perspective on the etiology of depression.

Authors:  Zachary Durisko; Benoit H Mulsant; Paul W Andrews
Journal:  J Affect Disord       Date:  2014-09-28       Impact factor: 4.839

3.  Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

Authors:  C G Lyketsos; M Steinberg; J T Tschanz; M C Norton; D C Steffens; J C Breitner
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

4.  Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

Authors:  M M Bassiony; M S Steinberg; A Warren; A Rosenblatt; A S Baker; C G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2000-02       Impact factor: 3.485

5.  Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.

Authors:  Sid E O'Bryant; Laura H Lacritz; James Hall; Stephen C Waring; Wenyaw Chan; Zeina G Khodr; Paul J Massman; Valerie Hobson; C Munro Cullum
Journal:  Arch Neurol       Date:  2010-06

6.  Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Authors:  Linda Mah; Malcolm A Binns; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2014-10-29       Impact factor: 4.105

7.  Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.

Authors:  Grace J Lee; Po H Lu; Xue Hua; Suh Lee; Stephanie Wu; Ken Nguyen; Edmond Teng; Alex D Leow; Clifford R Jack; Arthur W Toga; Michael W Weiner; George Bartzokis; Paul M Thompson
Journal:  Biol Psychiatry       Date:  2012-02-08       Impact factor: 13.382

8.  The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.

Authors:  Elise A Weamer; James E Emanuel; Daniel Varon; Sachiko Miyahara; Patricia A Wilkosz; Oscar L Lopez; Steven T Dekosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2008-09-25       Impact factor: 3.878

Review 9.  Origins of delusions in Alzheimer's disease.

Authors:  Suzanne J Reeves; Rebecca L Gould; John F Powell; Robert J Howard
Journal:  Neurosci Biobehav Rev       Date:  2012-08-11       Impact factor: 8.989

Review 10.  Psychosis in Alzheimer's disease.

Authors:  Patrick S Murray; Sanjeev Kumar; Mary Ann A Demichele-Sweet; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2013-10-06       Impact factor: 13.382

View more
  3 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Validation of a Brief Multi-Dimensional Assessment of Dementia Severity.

Authors:  John D Peipert; Lee A Jennings; Tahmineh Romero; Ron D Hays; Neil S Wenger; Emmett Keeler; David B Reuben
Journal:  J Am Geriatr Soc       Date:  2020-11-30       Impact factor: 5.562

3.  Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis.

Authors:  J J Gomar; G Tan; J Halpern; M L Gordon; B Greenwald; J Koppel
Journal:  Transl Psychiatry       Date:  2022-02-26       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.